Objeetive：To discuss the clinical outcomes of portal vein stenting combined with transeatheter hepatic arterial ehemoembolization （TACE） in treating portal vein tumor thrombus in the patients with primary hepatic carcinoma （PHC）. Methods： Eleven PHC patients with tumor thrombus in the main branch or trunk of the portal vein were treated with stenting and TACE simultaneously （or TACE were performed 1 week later）. The successful rate of the procedure, the pateney of the obstruction, the complications, the mortality and the survival periods were all recorded. Results： Portal vein puncture was sueeessfully performed in all 11 eases and successful stenting was achieved in 10 eases. Hepatic eneephalopathy combined with hepatic failure was noticed in 1 patient. The median pateney period after stenting was 5.7 （1-18） months. The survival rates of patients at 3, 6 and 12 months after treatment were 5/ 11,4/ 11 and 2/ 11, respectively. Conelusion： Metallic stent implantation combined with TACE has satisfactory outcome in treating tumor thrombus in the main branch and trunk of the portal vein in PHC patients without distant metastases.